Literature DB >> 7781695

Discriminative stimulus effects of anandamide in rats.

J Wiley1, R Balster, B Martin.   

Abstract

Anandamide (arachidonylethanolamide), a putative endogenous ligand for the cannabinoid receptor, produces a tetrad of behavioral effects in mice characteristic of psychoactive cannabinoids including catalepsy, antinociception, hypothermia, and hypomobility. The present study examined the discriminative stimulus effects of anandamide in rats trained to discriminate delta 9-tetrahydrocannabinol or the potent cannabinoid receptor ligand CP 55,940 [(-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)-phenyl]-trans-4-(3- hydroxypropyl)cyclohexanol)] from vehicle. Intraperitoneal injections of anandamide substituted for delta 9-tetrahydrocannabinol and for CP 55,940; however, unlike substitution dose-effect curves with the training drugs, anandamide substitution occurred at a single dose (30 or 45 mg/kg) and was accompanied by severe decreases in response rates. The results of the present study suggest that, although systemic anandamide administration may have cannabimimetic effects similar to those of delta 9-tetrahydrocannabinol and CP 55,940, some differences in the behavioral effects of anandamide and other psychoactive cannabinoids also are apparent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781695     DOI: 10.1016/0014-2999(95)00010-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.

Authors:  Torbjörn U C Järbe; Quian Liu; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

2.  Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

Authors:  Jenny L Wiley; D Matthew Walentiny; Robert E Vann; Cassandra Y Baskfield
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.

Authors:  Jennifer L Stewart; Lance R McMahon
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride.

Authors:  R E Vann; D M Walentiny; J J Burston; K M Tobey; T F Gamage; J L Wiley
Journal:  Neuropharmacology       Date:  2011-10-31       Impact factor: 5.250

5.  Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury.

Authors:  Jérémie Joffre; Che-Chung Yeh; Erika Wong; Mayuri Thete; Fengyun Xu; Ivana Zlatanova; Elliot Lloyd; Lester Kobzik; Matthieu Legrand; Judith Hellman
Journal:  J Immunol       Date:  2020-05-08       Impact factor: 5.422

Review 6.  Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Authors:  Zuzana Justinova; Steven R Goldberg; Stephen J Heishman; Gianluigi Tanda
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

7.  Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.

Authors:  Bogna Ignatowska-Jankowska; Jenny L Wilkerson; Mohammed Mustafa; Rehab Abdullah; Micah Niphakis; Jenny L Wiley; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2015-03-11       Impact factor: 4.030

8.  Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats.

Authors:  Jennifer E Murray; Nicole R Wells; George D Lyford; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

Review 9.  Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Pharmacol Ther       Date:  2013-01-16       Impact factor: 12.310

10.  Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.

Authors:  Lance R McMahon
Journal:  Psychopharmacology (Berl)       Date:  2008-07-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.